Rituximab Administration in Third Trimester of Pregnancy Suppresses Neonatal B-Cell Development
Figure 1
Flow cytometric analysis of
peripheral blood lymphocytes, taken from the neonate at the age of six months,
indicating the presence of CD19 positive B-lymphocytes (20% on average; (a) and (b)),
expressing the maturation marker CD20 (99%; (a), and partly expressing the
memory marker CD27 (7%; (b). Analysis was done within the CD45 positive total
lymphocyte gate.
